Literature DB >> 11929132

The interleukin-10 family of cytokines.

Helmut Fickenscher1, Simon Hör, Heide Küpers, Andrea Knappe, Sabine Wittmann, Heinrich Sticht.   

Abstract

A family of interleukin-10 (IL-10)-related cytokines has emerged, comprising a series of herpesviral and poxviral members and several cellular sequence paralogs, including IL-19, IL-20, IL-22 [IL-10-related T-cell-derived inducible factor (IL-TIF)], IL-24 [melanoma differentiation-associated antigen 7 (MDA-7)] and IL-26 (AK155). Although the predicted helical structure of these homodimeric molecules is conserved, certain receptor-binding residues are variable and define the interaction with specific heterodimers of different type-2 cytokine receptors. This leads, through the activation of signal transducer and activator of transcription (STAT) factors, to diverse biological effects. For example, whereas IL-10 is a well-studied pleiotropic immunosuppressive and immunostimulatory cytokine, IL-22/IL-TIF mediates acute-phase response signals in hepatocytes and IL-20 induces the hyperproliferation of keratinocytes, which has been proposed as a pathogenic mechanism of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929132     DOI: 10.1016/s1471-4906(01)02149-4

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  66 in total

Review 1.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Takayuki Iida; Masami Yamada; Yoshihiko Sato; Ken Takeuchi; Tatsuo Tanaka; Kenji Kondo; Masataka Kikuyama; Yasuhiko Maruyama; Yasushi Iwaoka; Akiko Nakamura; Kazuhisa Hirayama; Abby R Saniabadi; Fumitoshi Watanabe
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study.

Authors:  G Fonseca-Camarillo; J Furuzawa-Carballeda; J Granados; J K Yamamoto-Furusho
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol.

Authors:  A Suryanarayanan; J M Carter; J D Landin; A L Morrow; D F Werner; I Spigelman
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

5.  NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages.

Authors:  Shanjin Cao; Xia Zhang; Justin P Edwards; David M Mosser
Journal:  J Biol Chem       Date:  2006-07-11       Impact factor: 5.157

6.  Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family.

Authors:  Dorothee Preimel; Heinrich Sticht
Journal:  J Mol Model       Date:  2004-07-09       Impact factor: 1.810

7.  Genome-wide transcriptional response of primary alveolar macrophages following infection with porcine reproductive and respiratory syndrome virus.

Authors:  Sem Genini; Peter L Delputte; Roberto Malinverni; Maria Cecere; Alessandra Stella; Hans J Nauwynck; Elisabetta Giuffra
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

8.  The genome of canarypox virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA.

Authors:  Arindam Chakrabarti; Anthony J Sadler; Niladri Kar; Howard A Young; Robert H Silverman; Bryan R G Williams
Journal:  J Biol Chem       Date:  2008-07-14       Impact factor: 5.157

10.  Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.

Authors:  E Sloane; S Langer; B Jekich; J Mahoney; T Hughes; M Frank; W Seibert; G Huberty; B Coats; J Harrison; D Klinman; S Poole; S Maier; K Johnson; R Chavez; L R Watkins; L Leinwand; E Milligan
Journal:  Gene Ther       Date:  2009-07-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.